Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Verena Tischler"'
Autor:
Roslind K. Hackenberg, Fabio Schmitt-Sánchez, Christoph Endler, Verena Tischler, Jayagopi Surendar, Kristian Welle, Koroush Kabir, Frank A. Schildberg
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 9, p 3057 (2023)
Osteomyelitis (OM) remains one of the most feared complications in bone surgery and trauma. Its diagnosis remains a major challenge due to lack of guidelines. The aim of this study was to prospectively analyze the value of the most common and availab
Externí odkaz:
https://doaj.org/article/84487b960cb94d3096672184be6d369c
Autor:
Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noemie Leblay, Graham Byrnes, Ruping Sun, Aurélien De Reynies, Anne McLeer-Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller, Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James D. McKay, Denis Moro-Sibilot, Christian G. Brambilla, Sylvie Lantuejoul, Nicolas Lemaitre, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund-Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, David Neil Hayes, Elisabeth Brambilla, Lynnette Fernandez-Cuesta, Roman K. Thomas
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
The molecular nature of large-cell neuroendocrine lung carcinomas (LCNEC) has remained unclear. Here, the authors show LCNECs represent a distinct transcriptional subgroup among lung cancers and comprise two molecular subgroups, type I (TP53 and STK1
Externí odkaz:
https://doaj.org/article/0b984304ba014836a34f2b6d1a57b335
Autor:
Uwe Schirmer, Heidi Fiegl, Marco Pfeifer, Alain G. Zeimet, Elisabeth Müller-Holzner, Peter K. Bode, Verena Tischler, Peter Altevogt
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-3 (2018)
Following publication of the original article [1], we have been alerted to errors in Figs. 2 and 8. In Fig. 2B, the GAPDH loading control for Hec1A cells is shown twice in error (in Fig. 2B and Fig. 2C). In Fig. 8, in testis case 1 (first column) the
Externí odkaz:
https://doaj.org/article/af281d7e721840a6b17876bbcfe04196
Autor:
Johannes Brägelmann, Marcel A. Dammert, Felix Dietlein, Johannes M. Heuckmann, Axel Choidas, Stefanie Böhm, André Richters, Debjit Basu, Verena Tischler, Carina Lorenz, Peter Habenberger, Zhizhou Fang, Sandra Ortiz-Cuaran, Frauke Leenders, Jan Eickhoff, Uwe Koch, Matthäus Getlik, Martin Termathe, Muhammad Sallouh, Zoltán Greff, Zoltán Varga, Hyatt Balke-Want, Christopher A. French, Martin Peifer, H. Christian Reinhardt, László Örfi, György Kéri, Sascha Ansén, Lukas C. Heukamp, Reinhard Büttner, Daniel Rauh, Bert M. Klebl, Roman K. Thomas, Martin L. Sos
Publikováno v:
Cell Reports, Vol 20, Iss 12, Pp 2833-2845 (2017)
Kinase inhibitors represent the backbone of targeted cancer therapy, yet only a limited number of oncogenic drivers are directly druggable. By interrogating the activity of 1,505 kinase inhibitors, we found that BRD4-NUT-rearranged NUT midline carcin
Externí odkaz:
https://doaj.org/article/65260813004b4d5e8d198b9f59d2baa6
Autor:
Verena Tischler
Publikováno v:
Die Pathologie. 43:130-133
Autor:
Konrad Steinestel, Verena Tischler
Publikováno v:
Die Pathologie. 43:172-175
Autor:
Thomas Depoilly, Simon Garinet, Léon C. van Kempen, Ed Schuuring, Sergi Clavé, Beatriz Bellosillo, Cristiana Ercolani, Simonetta Buglioni, Janna Siemanowski, Sabine Merkelbach-Bruse, Verena Tischler, Melanie-Christin Demes, Henry Paridaens, Catherine Sibille, Vincent Thomas de Montpreville, Etienne Rouleau, Artur Bartczak, Monika Pasieka-Lis, Ryan Yee Wei Teo, Khoon Leong Chuah, Marta Barbosa, Carlos Quintana, Michele Biscuola, Mercedes Delgado-Garcia, Davide Vacirca, Alessandra Rappa, Matthew Cashmore, Matthew Smith, Piotr Jasionowicz, Adam Meeney, Patrice Desmeules, Benoit Terris, Audrey Mansuet-Lupo
Publikováno v:
Journal of molecular diagnostics, 24(9), 1021-1030. ELSEVIER SCIENCE INC
Targeted therapy in lung cancer requires the assessment of multiple oncogenic driver alterations, including fusion genes. This retrospective study evaluated the Idylla GeneFusion prototype, an automated and ease-of-use (
Autor:
Roman K. Thomas, Reinhard Büttner, Jürgen Wolf, Martin Peifer, Alex Soltermann, Martin L. Sos, Sascha Ansén, Julie George, Johannes M. Heuckmann, Roopika Menon, Johannes Brägelmann, Ilona Dahmen, Sebastian Michels, Verena Tischler, Roberta Castiglione, Daniel Schütte, Meryem Ercanoglu, Florian Malchers
Supplementary Figure 1 Short Tandem Repeat Analysis for H1581 and DMS114 Cells; Supplementary Figure 2 Genomic Alteration Validation of NRAS and DUSP6; Supplementary Figure 3 Genomic Differences in DMS114 and DMS114_BGJp Cells; Supplementary Figure 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6984da2fa9931ec9eb76f15675cc31
https://doi.org/10.1158/1078-0432.22468094
https://doi.org/10.1158/1078-0432.22468094
Autor:
Alessandra Curioni-Fontecedro, Maries van den Broek, Davide Soldini, Christian Britschgi, Verena Tischler, Rolf A. Stahel, Emanuela Felley-Bosco, Paul Stolzmann, Walter Weder, Bart Vrugt, Isabelle Opitz, Beata Bode, Martina Friess, Hideo Yagita, Stefanie Hiltbrunner, Virginia Cecconi, Paulino Tallón de Lara
Supplementary data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c08ae8245224a3028577830e62bf84
https://doi.org/10.1158/1078-0432.22468337.v1
https://doi.org/10.1158/1078-0432.22468337.v1
Autor:
Roman K. Thomas, Reinhard Büttner, Jürgen Wolf, Martin Peifer, Alex Soltermann, Martin L. Sos, Sascha Ansén, Julie George, Johannes M. Heuckmann, Roopika Menon, Johannes Brägelmann, Ilona Dahmen, Sebastian Michels, Verena Tischler, Roberta Castiglione, Daniel Schütte, Meryem Ercanoglu, Florian Malchers
Purpose: The 8p12-p11 locus is frequently amplified in squamous cell lung cancer (SQLC); the receptor tyrosine kinase fibroblast growth factor receptor 1 (FGFR1) being one of the most prominent targets of this amplification. Thus, small molecules inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1503590a657fe5fc1ca1abe05b82e9
https://doi.org/10.1158/1078-0432.c.6526835.v1
https://doi.org/10.1158/1078-0432.c.6526835.v1